Cécile Moluçon‐Chabrot

Centre Hospitalier Universitaire de Clermont-Ferrand — France

Medicine · Health Sciences

23h-index2.6kcitations89works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(40), CNS Lymphoma Diagnosis and Treatment(34), Glioma Diagnosis and Treatment(13), Chronic Lymphocytic Leukemia Research(13), Viral-associated cancers and disorders(10)

Publications88 total

First results of the methoglu Trial, a phase 1 Trial from the LOC network evaluating the reduction of the time interval between methotrexate perfusions combined with glucarpidase in relapsed primary CNS lymphomas
Blood·2025Open Access
Results of the primary end-point of the LOC-R01: A randomized phase II Study of lenalidomide and ibrutinib in association with rituximab-methotrexate procarbazine vincristin (R-MPV) as a targeted induction treatment for patients aged 18 to 65 with a newly diagnosed primary central nervous system lymphoma (PCNSL)
Blood·2025
The addition of a tyrosine kinase inhibitor to intensive chemotherapy significantly improves outcome in de novo BCR::ABL1+ acute myeloid leukemia treated with intensive chemotherapy
Blood·2025
P14.07.B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORK
Neuro-Oncology·2025Open Access
Automatic Segmentation of Primary Central Nervous System Lymphoma at Clinical Routine Postcontrast T1-weighted MRI
Radiology Imaging Cancer·2025Open Access
An Overview of Isavuconazole Clinical Use: A Multicentre Analysis of Indications, Exposure and Hepatic Safety
Clinical Drug Investigation·2025· 4 citedOpen Access
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study
Annals of Neurology·2024· 7 citedOpen Access
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study
Bone Marrow Transplantation·2024· 3 citedOpen Access
P20.17.B PRIMARY CEREBRAL T-CELL LYMPHOMAS DISPLAY AN ATYPICAL PRESENTATION: A LOC STUDY
Neuro-Oncology·2024Open Access
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: A LOC network study
2024Open Access
Deciphering Unexpected Vascular Locations of <i>Scedosporium</i> spp. and <i>Lomentospora prolificans</i> Fungal Infections, France
Emerging infectious diseases·2024Open Access
Successful treatment of de novo acute myeloid leukaemia associated aortitis by induction chemotherapy alone
Mediterranean Journal of Hematology and Infectious Diseases·2024Open Access
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of &lt;i&gt;TP53&lt;/i&gt; mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica·2023· 3 citedOpen Access
Intérêt du dosage de l’haptoglobine pour juger de l’observance des patients PR traités par tocilizumab
Revue du Rhumatisme·2023
Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program
Blood·2023Open Access
P776: ATGAM EFFICACY AND SAFETY IN MODERATE AND SEVERE ACQUIRED APLASTIC ANEMIA: OUTCOME OF A LARGE MULTICENTER COHORT OF 634 CHILDREN AND ADULTS FROM THE FRENCH AUTHORIZATION FOR TEMPORARY USE SURVEILLANCE PROGRAM
HemaSphere·2023Open Access
Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
Hematological Oncology·2023Open Access
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era
Leukemia & lymphoma/Leukemia and lymphoma·2022
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
Journal of Clinical Oncology·2022· 89 cited
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
Blood Advances·2022· 25 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Rémy Gressin(23), Caroline Houillier(22), Carole Soussain(21), Khê Hoang‐Xuan(21), Sylvain Choquet(19), Roch Houot(19), Nathalie Cassoux(15), Gandhi Damaj(15), Valérie Touitou(14), Emmanuel Gyan(14), Hervé Ghesquières(13), Olivier Chinot(13), Guido Ahle(13), Fabrice Jardin(13), Adrian Tempescul(13), Vincent Delwail(12), Franck Morschhauser(11), Anna Schmitt(11), Luc Taillandier(10), Adrien Chauchet(9)